SiliconInvestor
     Advanced Search   [ sign in ]

register
Register

 Biotech / Medical | Provectus Pharmaceuticals Inc.

Previous 10 | Next 10 
To: pvct investor who wrote (6535)6/4/2010 1:44:30 PM
From: ShootU2   of 11958
 
Another way of looking at it if I can use an analogy.

If you have a guy on your team that is batting 3 times your average (i.e., Objective Response Rate) who is the FDA likely to send to the plate?

Or what drug would a consumer use in the market place?

If ipilimumab is getting attention, then like a springboard some smart analysts are going to say look at what PH10 is doing.

Hey, lets use BM/ipilimumab as the straightman.

Share Recommend | Keep | Reply | Mark as Last Read

From: pvct investor6/4/2010 1:44:39 PM
   of 11958
 
There is content circulating [today] that some of you may have received or of which some of you may be aware. The substance appears to be credible. We thought we'd share...

According to the source [of the above content] who purportedly spoke to Dr. Piros*, if the company presents data demonstrating [significant] reduction in visceral tumors, as part of the MM P2 trial, Piros is said to believe PV-10 would be a game changer as it relates to cancer treatment.

Game changer, eh?

* R&R's research analyst covering Provectus and recently ranked #1 biotechnology analyst

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (2)

To: pvct investor who wrote (6527)6/4/2010 1:54:52 PM
From: jm2i123   of 11958
 
I find quite amazing that so called scientific journalists do not even mention Provectus in such targeted articles. the media buzz nothing less.

Share Recommend | Keep | Reply | Mark as Last Read

To: pvct investor who wrote (6531)6/4/2010 1:57:58 PM
From: jm2i123   of 11958
 
brilliant. i can take the calls. that will help them understanding what pv-10 does

Share Recommend | Keep | Reply | Mark as Last Read

To: pvct investor who wrote (6537)6/4/2010 2:02:14 PM
From: jm2i123   of 11958
 
That is a huge off the record statement. The champagne is in the fridge. We never know...

Share Recommend | Keep | Reply | Mark as Last Read

From: jm2i1236/4/2010 2:05:45 PM
   of 11958
 
pvctinvestor, is John F Thompson, (MD Principal Investigator pv-10 trials) at Asco?
thanks.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: jm2i123 who wrote (6541)6/4/2010 2:19:26 PM
From: pvct investor   of 11958
 
Yes (as will Professor Hersey).

Share Recommend | Keep | Reply | Mark as Last Read

To: pvct investor who wrote (6537)6/4/2010 3:05:09 PM
From: knucklehead   of 11958
 
If the results are fantastic, maybe a national TV network will pick up on the news. PVCT could use the publicity.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)

To: knucklehead who wrote (6543)6/4/2010 3:55:19 PM
From: Howard Williams   of 11958
 
Looks like some ASCO foreplay at the PVCT trading desk. Nice volume heading toward the close.

GLTA!

Share Recommend | Keep | Reply | Mark as Last Read

From: pvct investor6/4/2010 4:01:38 PM
1 Recommendation   of 11958
 
Channel checks indicate a contralateral tumor treated in a patient disappeared.

Share Recommend | Keep | Reply | Mark as Last Read | Read Replies (1)
Previous 10 | Next 10 

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQ
Copyright © 1995-2013 Knight Sac Media. All rights reserved.